SUSQUEHANNA ADVISORS GROUP, INC.
Position in LGND — Ligand Pharmaceuticals Inc
CIK 1444949
BALA CYNWYD, PA
Position in LGND
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$14,097,614
New position
Shares Held
44,600
first reported quarter
Ownership
0.224%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#72
of 415 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026SUSQUEHANNA ADVISORS GROUP, INC. holds $14,097,614 across 1 Biotechnology name. LGND ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
This page
|
44,600 | $14,097,614 |
All Filings in LGND
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,097,614 | 44,600 | Shares | Other | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||